Effects of a single dose of an intranasal feline herpesvirus 1, calicivirus, and panleukopenia vaccine on clinical signs and virus shedding after challenge with virulent feline herpesvirus 1

Journal of Feline Medicine and Surgery

Volumn 8, Issue 3, 2006, Pages 158-163

  Lappin, Michael R ^a   Sebring, Randal W ^b   Porter, Marilyn ^b   Radecki, Steven J ^c   Veir, Julia ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b HESKA CORPORATION   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY; VIRUS VACCINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CALICIVIRUS; CAT; CAT DISEASE; HERPES VIRUS; HERPES VIRUS INFECTION; IMMUNOLOGY; VIRUS INFECTION; VIRUS SHEDDING;

ANIMALS; ANTIBODIES, VIRAL; CALICIVIRIDAE INFECTIONS; CALICIVIRUS, FELINE; CAT DISEASES; CATS; FELINE PANLEUKOPENIA; HERPESVIRIDAE; HERPESVIRIDAE INFECTIONS; VIRAL VACCINES; VIRUS SHEDDING;

CALICIVIRIDAE; FELID HERPESVIRUS 1; HUMAN HERPESVIRUS 1;

EID: 33646167465     PISSN: 1098612X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfms.2005.12.001     Document Type: Article

References (21)

1. Binns S.H., Dawson S., Speakman A.J., Cuevas L.E., Hart C.A., Gaskell C.J., Morgan K.L., and Gaskell R.M. A study of feline upper respiratory tract disease with reference to prevalence and risk factors for infection with feline calicivirus and feline herpesvirus. Journal of Feline Medicine and Surgery 2 (2000) 123-133
2. Burton G., and Mason K.V. Do postvaccinal sarcomas occur in Australian kittens?. Australian Veterinary Journal 75 (1997) 102-106
3. Cocker F.M., Gaskett R.M., Newby T.J., Gaskell C.J., Stokes C.R., and Bourne F.J. Efficacy of early (48 and 96 h) protection against feline viral rhinotracheitis following intranasal vaccination with a live temperature sensitive mutant. Veterinary Record 114 (1983) 353-354
4. Cocker F.M., Newby T.J., Gaskell R.M., Evans P.A., Gaskell C.J., Stokes C.R., Harbour D.A., and Bourne J.F. Responses of kittens to nasal vaccination with a live, modified feline herpesvirus type 1. Research in Veterinary Science 41 (1986) 323-330
5. Davis E.V., and Beckenhauer W.H. Studies on the safety and efficacy of an intranasal feline rhinotracheitis-calicivirus vaccine. Veterinary Medicine for the small Animal Clinician 71 (1976) 1405-1410
6. Edinboro C.H., Janowitz L.K., Guptill-Yoran L., and Glickman L.T. A clinical trial of intranasal and subcutaneous vaccines to prevent upper respiratory infection in kittens at an animal shelter. Feline Practice 27 (1999) 7-13
7. Folkers C., and Hoogenboom A.M.M. Intranasal vaccination against upper respiratory tract disease (URD) in the cat - I. Virological and serological observations in kittens suffering from URD. Compendium on Immunology and Microbiology of Infectious Disease 1 (1978) 37-41
8. Harbour D.A., Howard P.E., and Gaskell R.M. Isolation of feline calicivirus and feline herpesvirus from domestic kittens 1980-1989. Veterinary Record 128 (1991) 77-80
9. Lappin M.R., Andrews J., Simpson D., and Jensen W.A. Use of serologic tests to predict resistance to feline herpesvirus 1, feline calicivirus, and feline parvovirus infection in kittens. Journal of the American Veterinary Medical Association 220 (2002) 38-42
10. Lappin M.R., Jensen W.A., Jensen T.D., Basaraba R.J., Brown C.A., and Radecki S.V. Investigation of the induction of antibodies against Crandall Rees feline kidney cell lysates and feline renal cell lysates after parenteral administration of vaccines against feline viral rhinotracheitis, calicivirus, and panleukopenia in kittens. American Journal of Veterinary Research 66 (2005) 506-511
11. Lappin M.R., Sebring R.W., Jensen W.A., Frank G.R., and Radecki S.V. Feline antibody responses to Crandell Reese Feline Kidney cell line extracts and feline renal cell extracts after administration of five different FVRCP vaccines. Journal of Veterinary Internal Medicine 1 (2004) 437
12. Lappin M.R., Veir J., Sebring R., and Radecki S.V. Feline lymphocyte blastogenesis in response to feline herpesvirus 1 antigens and concanavalin A after vaccination with five FVRCP vaccines. Journal of Veterinary Internal Medicine 19 (2005) 467
13. Nasisse M.P., Guy J.S., Stevens J.B., English R.V., and Davidson M.G. Clinical and laboratory findings in chronic conjunctivitis in kittens: 91 cases (1983-1991). Journal of the American Veterinary Medical Association 203 (1993) 834-837
14. Orr C.M., and Gaskell C.J. Interaction of an intranasal combined feline viral rhinotracheitis, feline calicivirus vaccine and the FVR carrier state. Veterinary Record 106 (1980) 164-166
15. Pedersen N.C., Sato R., Foley J.E., and Poland A.M. Common virus infections in kittens, before and after being placed in shelters, with emphasis on feline enteric coronavirus. Journal of Feline Medicine and Surgery 6 (2004) 83-88
16. Richards J., Rodan I., Elston T., Flemming D., Ford R., Henry S., Hustead D., Lappin M., Paul M., Rosen D., Scherk M., Scott F., and Welborn L. Feline vaccine selection and administration. Compendium on Continuing Education for the Practicing Veterinarian 23 (2001) 71-80
17. Scott F.W., and Geissinger C.M. Long term immunity in kittens vaccinated with an inactivated trivalent vaccine. American Journal of Veterinary Research 60 (1999) 652-658
18. Slater E., and York C. Comparative studies on parenteral and intranasal inoculation of an attenuated feline herpes virus. Proceedings of the 14th Congress I.A.B.S. 1975. Developments in Biological Standardization Vol 33 (1976), S Karger, Basel p 410
19. Stiles J. Feline herpesvirus. Clinical Techniques in Small Animal Practice 18 (2003) 178-185
20. Veir J.K., Ruch-Gallie R., Spindel M.E., and Lappin M.R. Prevalence of FHV-1, Mycoplasma spp., and aerobic bacteria in shelter kittens with acute upper respiratory tract disease. Journal of Veterinary Internal Medicine 18 (2004) 437
21. Weigler B.J., Guy J.S., Nasisse M.P., Hancock S.I., and Sherry B. Effect of a live attenuated intranasal vaccine on latency and shedding of feline herpesvirus 1 in domestic kittens. Archives of Virology 142 (1997) 2389-2400